期刊文献+

阿霉素对大鼠肺缺血再灌注损伤的保护作用 被引量:3

Protective effects of adriamycin against lung ischemia-reperfusion injury in rats
下载PDF
导出
摘要 目的观察阿霉素对大鼠肺缺血再灌注损伤(LIRI)的保护作用及其可能的机制。方法建立大鼠在体肺缺血再灌注模型。将健康Wistar大鼠54只随机分为手术对照组(C组)、缺血再灌注组(IR组)、阿霉素组(A组)。每组分别在缺血45min,再灌注60、120min3个时点处死6只大鼠,留取血浆和右肺组织,测定血清丙二醛(MDA)含量、肺组织干湿质量比值(D/W)、髓过氧化物酶(MPO)活性及肺组织中细胞凋亡指数(AI),并进行肺组织病理学检查。结果再灌注期间IR组MPO活性、AI、血清MDA升高,D/W降低,而预先给予阿霉素干预后可以减弱缺血再灌注诱导上述指标的变化。肺组织病理学检查显示阿霉素预先给药减轻肺缺血再灌注损伤。结论阿霉素对肺缺血再灌注损伤有保护作用,可能与其抑制氧自由基生成、中性粒细胞浸润及细胞凋亡有关。 Objective To investigate the protective effects of adriamycin on lung ischemia-reperfusion injury in rats and its possible mechanisms. Methods Rat models of lung ischemia-reperfusion were established. Fifty-four healthy Wistar rats were randomly divided into three groups: surgical controls (C group), isehemia-reperfusion group OR group) and adriamyein-pretreatod group (A group). At each of three time spots (45min from isehemia, 60 rain and 120min from reperfusion), every 6 rats from the groups were sacrificed, collected for plasma sample and the whole fight lung. The plasma contents of malondialdehyde (MDA), the dry/wet (D/W) weight ratio of the lung, activity of myeloperoxidase (MPO), and apoptotic index (AI) in lung tissue were determined. Histopathological study of the lung tissue was also performed. Results The plasma contents of MDA, MPO activity and AI in lung tissue were all significantly increased during reperfusion in IR group, while the D/W ratio of lung were lower than those in the other groups. Pretreatment with adriamycin was found to attenuate the abnormality in these parameters induced by IR. Pathological examination showed that the IR induced injury was also ameliorated with adriamycin pretreatment. Conclusion Adriamycin treatment before ischemia appeared to protect the lungs against IR induced injury, possibly by inhibited PMN infiltration, reduced production of oxygen radicals and suppressed apoptosis of lung tissue.
出处 《中国药物与临床》 CAS 2009年第5期388-390,共3页 Chinese Remedies & Clinics
基金 山西省卫生厅科技攻关项目(200608)
关键词 活性氧 细胞凋亡 过氧化物酶 阿霉素 缺血再灌注损伤 Reactive oxygenspecies Apoptosis Peroxidase Adriamycin Reperfusioninjury
  • 相关文献

参考文献6

  • 1Ito K,Ozasa H,Kojima N,et al.Pharmacological preconditioning protects lung injury induced by intestinal ischemia/reperfusion in rat.Shock,2003,19(5):462-468.
  • 2王晓杨.肺缺血再灌注损伤中细胞因子的作用[J].医学理论与实践,2005,18(3):251-253. 被引量:16
  • 3Eppinger MJ,Jones ML,Deeb GM,et al.Pattern of injury and the role of neutrophils in reperfusion injury of rat lung.J Surg Res,1995,58:713-718.
  • 4Fisher S,Cassivi SD,Xavier AM,et al.Cell death in human lung transplantion:apoptosis induction in human lung during ischemia and after transplantation.Ann Thorac Surg,2000,231:424-431.
  • 5李世红,王绍军.阿霉素心脏毒性发病机制新近展[J].临床心血管病杂志,2005,21(4):249-252. 被引量:19
  • 6Lee HJ,Lee MG.Pharmaco-kinetics of adriamycin and adriamycinol after intravenous administration of adriamycin to rats with water-deprivation for 48 hours.Res Commun Mol Pathol Pharmacol,1997,96 (2):299-306.

二级参考文献28

  • 1Swain S M, Whaley F S, Ewer M S.Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer,2003,97:2869-2879.
  • 2Muraoka S, Miura T.Free radicals mediate cardiac toxicity induced by adriamycin. Yakugaku Zasshi, 2003,123:855-866.
  • 3Wallace K B.Doxorubicin induced cardiac mitochondrionopathy.Pharmacol Toxicol, 2003 ,93:105-115.
  • 4Lebrecht D, Setzer B, Ketelsen U P,et al.Time dependent and tissue specific accumulation of mtDNA and respiratory chain defects in chronic doxorubicin cardiomyopathy. Circulation,2003,108:2423-2429.
  • 5Kwok J C, Richardson D R.Anthracyclines induce accumulation of iron in ferritin in myocardial and neoplastic cells: inhibition of the ferritin iron mobilization pathway. Mol Pharmacol,2003,63:849-861.
  • 6Kwok J C, Richardson D R.Examination of the mechanism(s) involved in doxorubicin-mediated iron accumulation in ferritin: studies using metabolic inhibitors, protein synthesis inhibitors, and lysosomotropic agents. Mol Pharmacol,2004,65:181-195.
  • 7Minotti G, Ronchi R, Salvatorelli E, et al. Cairo G.Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy. Cancer Res,2001,61:8422-8428.
  • 8Minotti G, Menna P, Salvatorelli E, et al.Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev, 2004 ,56:185-229.
  • 9Corna G, Santambrogio P, Minotti G, et al.Doxorubicin paradoxically protects cardiomyocytes against iron-mediated toxicity: role of reactive oxygen species and ferritin. J Biol Chem, 2004 ,279:13738-13745.
  • 10Kalyanaraman B, Joseph J, Kalivendi S, et al.Doxorubicin-induced apoptosis: implications in cardiotoxicity.Mol Cell Biochem, 2002 ,234-235:119-124.

共引文献33

同被引文献33

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部